ClinicalTrials.gov
ClinicalTrials.gov Menu

Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer (HER-ception)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01400438
Recruitment Status : Completed
First Posted : July 22, 2011
Last Update Posted : July 21, 2016
Sponsor:
Information provided by (Responsible Party):
Centre Francois Baclesse

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2015
  Actual Study Completion Date : September 2015